This study aims to identify the IDH1/2 mutation rate in adult patients (older than 18 yearolds) with diffuse gliomas and evaluate the association between IDH1/2 mutation status and demographics characteristics, clinical and radiographic features; (3) evaluate the prognosis role of IDH1/2 mutation status.